qtrly revenue $493 million versus refinitiv ibes estimate of $498.7 million.
qtrly total births at hospitals where we provided nicu services increased 2.8% on a same-unit basis.
qtrly net sales decreased $4 million sequentially to $4 billion.
qtrly net sales $0.5 million versus refinitiv ibes estimate of $1.1 billion.
qtrly maternal fetal medicine volume increased 8.6% on office-based basis.
qtrly hospital volumes increased 4.4% on a same unit basis.
compname reports q3 earnings per share of $0.49.
sees fy 2021 adjusted ebitda of at least $250 million.
compname reports q2 2021 results and announces $1 billion share repurchase program.
q3 revenue $4.2 billion versus refinitiv ibes estimate of $3.7 billion.
sees fy adjusted ebitda to exceed $270 million.
sees fy 2021 adjusted ebitda to be about 2.5 times higher than 2020.
sees opportunity for us to open more than 100 pediatric clinics across our footprint within a few years.
qtrly pediatric hospitalist volumes increased 14%.
qtrly revenue cycle management efficiency was driven by improving revenue cycle efficiency, recruiting the best talent and focused managerial actions.
compname reports q2 earnings per share of $0.20.
